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Although hepatocyte growth factor (HGF)
and plasminogen may have evolved from
a common ancestor in vertebrates, no
ancestral form has been identified in
other lineages. Hisamoto et al. report
that C. elegans SVH-1 may be an ances-
tral form of HGF and plasminogen and
acts as both a growth factor and a
protease.
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Hepatocyte growth factor (HGF) and fibrinolytic
serine protease plasminogen may have evolved
from a common ancestor in vertebrates. This has
been hard to ascertain, as no ancestral form has
been identified in other lineages. In Caenorhabditis
elegans, an HGF/plasminogen-like protein SVH-1
regulates axon regeneration via the HGF receptor
homolog SVH-2. In this study, we report that both
the svh-1 and svh-2 genes are conserved in many
invertebrates. We also show that SVH-1 has an
additional function, independent of SVH-2, which
controls larval growth. SVH-1 protease activity is
essential for larval growth, but not for axon regener-
ation. Deletion of svh-1 causes abnormal accumula-
tion of FBL-1 protein, an extracellular matrix (ECM)
component fibulin, around the pharynx, and this
growth defect is partially suppressed by FBL-1
depletion. These results suggest that SVH-1 acts
as both a growth factor and a protease, and they
also provide insights into the evolution of HGF/plas-
minogen in animals.
INTRODUCTION
Plasminogen family proteins are defined by the presence of krin-
gle and trypsin-like serine protease domains and are conserved
among vertebrates (Hughes, 2000; Doolittle, 2011). In mammals,
the plasminogen family includes hepatocyte growth factor
(HGF), macrophage stimulating protein (MSP), and plasminogen
(Donate et al., 1994; Hughes, 2000). HGF andMSP act as growth
factors for the receptor tyrosine kinases Met and Ron, respec-
tively. Binding of HGF to Met or MSP to Ron induces the activa-
tion of a complex set of intracellular pathways that lead to cell
migration, branchingmorphogenesis, and proliferation (Gherardi
et al., 2012). However, neither HGF nor MSP function as prote-
ases, as they lack the essential Asp-His-Ser catalytic triad found
in all serine proteases (Donate et al., 1994). This is in contrast to
plasminogen, which has intact catalytic triad and functions as a
protease, but not as a growth factor. Plasminogen is critical for
the maintenance of homeostasis and vascular patency and
also seems to be important in tissue remodeling (Bugge et al.,
1995; Romer et al., 1996; Lund et al., 2000). Plasminogen-defi-1628 Cell Reports 9, 1628–1634, December 11, 2014 ª2014 The Autcient mice develop to term, grow to adulthood, and are capable
of reproduction (Bugge et al., 1995); however, they suffer from
progressive microvascular thrombosis, delayed wound healing,
and reduced life expectancy (Bugge et al., 1995; Romer et al.,
1996). Plasminogen may therefore have a broad range of func-
tions in specialized settings through its role in the degradation
of extracellular matrix (ECM) (Vassalli et al., 1991). However,
the precise biochemical role(s) of plasminogen in the processes
of ECM dissolution and tissue remodeling has not been well
defined.
Previous molecular phylogenetic analysis has indicated
that HGF, MSP, and plasminogen may all have arisen by gene
duplication from a common ancestral gene (Donate et al.,
1994; Hughes, 2000). HGF and MSP, as well as their receptors
Met/Ron, and plasminogen are also conserved in zebrafish (Bas-
sett, 2003; Cheng et al., 2006; Huitema et al., 2012). In contrast,
basal chordates have only plasminogen-like proteins that
contain an intact catalytic triad in their protease domains (Liu
and Zhang, 2009; Doolittle, 2011; Ponczek et al., 2012). Because
a common ancestor for both HGF/MSP and plasminogen has not
been identified, it remains unclear whether the growth-factor-like
function was acquired posteriori during the evolution of a plas-
minogen-like protein or whether an ancient protein having dual
functions evolutionarily diverged into two functionally distinct
proteins.
The Caenorhabditis elegans SVH-1 protein belongs to the
plasminogen family (Figure 1A). Recently, we have demon-
strated that SVH-1 regulates axon regeneration by acting as
a ligand for the Met/Ron-like receptor tyrosine kinase SVH-2,
which activates a JNK mitogen-activated protein kinase
cascade (Li et al., 2012). Interestingly, SVH-1 possesses an
intact catalytic triad similar to plasminogen, implying its
possible function as a protease. However, this catalytic triad
is not required for axon regeneration, and its physiological
role has been unknown. In this study, we found that larval
development of svh-1 null mutants is arrested at the L2 stage.
This effect of SVH-1 on larval growth is apparently independent
of the SVH-2–JNK pathway, as the svh-2 null mutation has no
effect on growth. Furthermore, we show that the protease activ-
ity of SVH-1 is essential for larval growth. Deletion of the svh-1
gene causes the abnormal accumulation of an ECM protein
fibulin around the pharynx, which leads to a progressive
dysfunction of pharyngeal pumping. Thus, SVH-1 acts as a
protease required for organ function. This study also suggests
the origin of a common ancestral gene for both HGF/MSP
and plasminogen.hors
Figure 1. Genome and Protein Structures of SVH-1
(A) Structure of SVH-1. Schematic diagrams ofC. elegansSVH-1, humanHGF/
MSP, and plasminogen are shown. Domains are shown as follows: a signal
peptide (black box), a C-type lectin domain (CL), a kringle domain (K), an LDL
receptor-like domain (L), a PAN domain (N), a scavenger receptor domain
(SCR), and a serine protease-like domain (SP).
(B) Phylogenetic tree depicting the genetic relationships among C. elegans
SVH-1, human HGF/MSP, plasminogen, and elastase. The sequences of the
protease-like domains in the indicated proteins were compared. Human
chymotrypsin was used as an outgroup. The scale bar represents the evolu-
tionary distance.
(C) Genome structure of the svh-1 gene. Exons are indicated by boxes, and
introns and untranslated regions are indicated by bars. The bold lines under-
neath indicate the extent of the deleted regions in the ok2531and tm2646
alleles. Colors correspond to those of domains shown in Figure 1A.RESULTS
Relationship between C. elegans SVH-1 andMammalian
HGF/Plasminogen
The svh-1 gene encodes a protein containing a signal peptide, a
C-type lectin domain, a kringle domain, two low-density lipopro-
tein (LDL) receptor-like domains, a PAN domain, a scavenger re-
ceptor-like domain, and a serine protease-like domain (Li et al.,
2012) (Figure 1A). Although SVH-1 possesses an intact catalytic
triad similar to plasminogen, this triad is not required for the abil-
ity of SVH-1 to function as an HGF/MSP-like growth factor that
controls axon regeneration via SVH-2, a Met/Ron-like growth
factor receptor homolog inC. elegans (Li et al., 2012). In contrast
to the highly structural similarity between SVH-2 and mammal
Met (Figure S1A), SVH-1 has a slightly different domain compo-
sition when compared to HGF/plasminogen (Figure 1A).
To understand the evolutionary origin of SVH-1, we searched
the genomic sequence databases of other invertebrate species
for genes whose products show similarity to C. elegans SVH-1.
We found several SVH-1-like proteins in protostomes, including
water flea, pea aphid, ant, bee, and oyster (Figure S1B). These
animals have only one SVH-1-like protein characterized by do-
mains of C-type lectin, kringle, LDL receptor-like, PAN, scav-
enger receptor-like, and serine protease with an intact catalytic
triad (Figure S2). We also found an SVH-1-like protein in an echi-Cell Renoderm sea urchin, although it lacks a C-type lectin domain (Fig-
ures S1B and S2). No vertebrate has been found that possesses
a serine protease precursor with a domain arrangement similar
to that seen in the sea urchin. The protochordate Branchiostoma
floridae has two SVH-1-like proteins (Bf-SVH-1-1 and Bf-SVH-
1-2) (Figure S1B), in addition to seven other kringle-containing
proteases (Ponczek et al., 2012). Interestingly, Bf-SVH-1-2 and
kringle-containing proteases possess intact catalytic triads,
whereas Bf-SVH-1-1 contains a ‘‘dead protease’’ (Figure S2). A
serine residue essential for protease function within the catalytic
triad is replaced by isoleucine (ATC codon) in Bf-SVH-1-1, while
the corresponding amino acid residue in HGF/MSP is tyrosine
(TAT or TAC codon). In addition, a phylogenetic analysis indi-
cates that Bf-SVH-1-1 diverged before the HGF/MSP-plasmin-
ogen evolutionary divergence (Figure S3). Therefore, Bf-SVH-1
may not be a direct ancestor of HGF/MSP. Phylogenetic analysis
focusing on the protease-like domains of human HGF/MSP
growth factors, plasminogen, C. elegans SVH-1, and SVH-1-
like proteins from other invertebrates suggests that C. elegans
SVH-1 and its related proteins in invertebrates diverged from
a common ancestral gene and that HGF/MSP diverged from
plasminogen after vertebrates and invertebrates had diverged
(Figures 1B and S3). Although prothrombin possesses kringle
domains, thrombin and elastase are outliers (Figures 1B and
S3), as are kringle-containing proteases in Branchiostoma
floridae. These results raise the possibility that the transition to
a ‘‘dead protease’’ (HGF) occurred late in deuterostome evolu-
tion, i.e., after the divergence of the lineage leading to inverte-
brates, including sea urchin and amphioxus. Thus, the functional
differentiation between HGF/MSP-like growth factors and plas-
minogen-like proteases presumably occurred in chordates.
SVH-1 Is Required for Larval Growth
We examined the physiological function of svh-1 by reverse
genetics, using the out-of-frame deletion mutations ok2531and
tm2646 that are presumed to be null alleles (Figure 1C). The origi-
nally isolated strain that carries the svh-1(ok2531)mutation has an
axon regeneration defect but is homozygous viable because of the
presenceof anextra copyof the svh-1gene fragment translocated
to the right end on LGX (see Supplemental Experimental Proce-
dures) (Li et al., 2012).When thisduplication (kmDp1)was removed
from the svh-1 (ok2531); kmDp1/+ strain, the resulting mutant,
svh-1(ok2531), failed to grow larger than the L2 larva body size
even after 5 days following hatching, whereas wild-type animals
and svh-1(ok2531); kmDp1/+ mutants became adults within
4 days (Figure 2A). A similar larval arrest phenotype was also
observed in svh-1(tm2646) homozygous mutants (data not
shown).
The svh-1 gene is expressed only in ADL sensory neurons (Li
et al., 2012). Consistent with this, the larval arrest phenotype of
svh-1(ok2531) was rescued by the expression of svh-1 in ADL
neurons by the srh-220 promoter (McCarroll et al., 2005) (Fig-
ure 2A). Furthermore, expression of svh-1 under the control of
Pjkk-1, a pan-neuronal promoter, also rescued the larval growth
defect in svh-1 mutants (see Figure 3B). SVH-1 regulates axon
regeneration via the SVH-2 receptor tyrosine kinase, which acti-
vates the KGB-1 JNK pathway (Li et al., 2012). However, neither
svh-2 nor kgb-1 deletion mutations had any effect on growthports 9, 1628–1634, December 11, 2014 ª2014 The Authors 1629
Figure 2. Phenotypes of svh-1 Deletion
Mutants
(A) Light microscopy of animals grown for 5 days.
Anterior is to the left. Scale bar, 50 mm.
(B) Morphology of wild-type L2 larva and svh-1
mutant animals 48 hr after hatching. White
brackets indicate intestines. In wild-type animals,
the intestine contains many gut granules (top
panel), whereas in svh-1 mutant animals, the in-
testine contains few gut granules and presents a
smooth appearance (bottom panel). Scale bar,
10 mm.
(C) Fluorescent bead ingestion. Wild-type L1 larva
and svh-1 mutant animals 48 hr after hatching
were incubated with FITC-conjugated 0.5 mm
polystyrene beads. Fluorescent/differential inter-
ference contrast (DIC) overlay images are shown.
Yellow lines indicate intestines. Wild-type N2
animals contain beads in the intestine, whereas
svh-1 mutants do not contain beads past the
metacorpus. Scale bar, 50 mm.
(D) Pharyngeal pumping rate. The pharyngeal
pumping rates in wild-type (blue) and svh-
1(ok2531) mutant (red) animals were determined
by manually counting the contractions of the
pharyngeal bulb. Vertical scale indicates the fre-
quency of pharyngeal pumping in 20 s intervals.
Horizontal scale indicates hours after hatching.
Error bars indicate 95% confidence interval.(Figure 2A), suggesting that SVH-1 controls larval growth inde-
pendent of the SVH-2-KGB-1 pathway.
SVH-1 Is Required for Normal Pharyngeal Pumping
We next examined the larval arrest phenotype in svh-1mutants.
Homozygous svh-1(ok2531)deletionmutantswere indistinguish-
able from wild-type in both morphology and body locomotion at
the time of hatching. However, within a few days, the mutants
started to exhibit symptoms of starvation: they appeared lean
and pale and their intestines contained only a few small gut gran-
ules (Figure 2B). These observations suggested that svh-1 null
mutants might have impaired food intake. To test this possibility,
svh-1(ok2531)mutants were fed with Escherichia coli (OP50) and
fluorescentmicropolystyrene beads, and ingestionwas analyzed
bymicroscopy. In contrast towild-typeL1 larvae,whichuniformly
contained beads throughout the entire intestinal tract, no beads1630 Cell Reports 9, 1628–1634, December 11, 2014 ª2014 The Authorswere observed in svh-1(ok2531) mutants
48 hr after hatching (Figure 2C).
C.elegans ingestionofbacteria relieson
synchronous pharyngeal muscle contrac-
tions called pharyngeal pumping (Albert-
son and Thomson, 1976). We therefore
compared pharyngeal pumping of svh-
1(ok2531) mutants with that of wild-type
animals by time-lapse video microscopy.
In wild-type animals, pharyngeal pumping
occurred rhythmically, and the average
frequency of pumping was constant
(Figure 2D; Movie S1). In contrast, in
svh-1 mutants, although the frequency ofpharyngeal pumpingappearednormal just after hatching, pharyn-
geal muscle contraction became irregular and the pumping fre-
quency greatly decreased by 48 hr after hatching (Figure 2D;
Movie S2). These data suggest that the inability of svh-1mutants
to take up foods is due to a defect in pharyngeal pumping.
SVH-1 Protease Activity Is Required for Larval Growth
To determine the functional domain(s) of SVH-1, we generated
a set of transgenes in which the jkk-1 promoter was used to
drive expression of various SVH-1 fragments (Figure 3A). For
each transgene, we scored svh-1(ok2531) and svh-1(ok2531);
kmDp1/+ mutants for progression to adulthood and axon regen-
eration following laser ablation, respectively. We found that
expression of wild-type svh-1 rescued defects in both larval
growth (Figure 3B) and axon regeneration in svh-1(ok2531)
mutants (Li et al., 2012). We have previously shown that
Figure 3. Domains of SVH-1 Essential for Its
Functions
(A) Protein diagrams and functions of SVH-1 do-
mains. Domains are depicted as in Figure 1A. Each
construct was expressed in svh-1 mutants under
the control of the jkk-1 promoter and the animals
assayed for larval growth and axon regeneration.
aData from previous results (Li et al., 2012).
(B) Light microscopy of animals grown for 5 days.
Anterior is to the left. Scale bar, 50 mm.
(C) Percentages of axons that had initiated
regeneration 24 hr after laser surgery. Error bars
indicate 95% confidence interval. The number of
severed axons is indicated by (n). *p < 0.05, **p <
0.01, ***p < 0.001.SVH-1DSS, a mutant lacking the N-terminal signal sequence
required for secretion (Li et al., 2012), is unable to rescue the
defect in axon regeneration of svh-1(ok2531); kmDp1/+ mutants
(Li et al., 2012). When larval growth was examined, we found that
the Pjkk-1::svh-1Dss gene failed to rescue the growth defect in
svh-1(ok2531) mutants (Figures 3A and 3B). Thus, secretion of
SVH-1 is required for the control of larval growth.
SVH-1 acts as a ligand for the SVH-2 receptor tyrosine kinase in
the regulation of axon regeneration (Li et al., 2012). MammalianCell Reports 9, 1628–1634, DeHGF, a ligand for Met, lacks the essential
Asp-His-Ser catalytic triad found in
serine proteases (Donate et al., 1994). In
contrast, SVH-1 contains this catalytic
triad (Li et al., 2012). We have previously
demonstrated that the svh-1(h755a)
mutant, in which His-755 in the Asp-His-
Ser catalytic triad has been replaced with
alanine, is able to rescue the svh-1 defect
in axon regeneration (Li et al., 2012) (Fig-
ure3A).However,we found that thismuta-
tion was unable to rescue the larval arrest
phenotype in svh-1(ok2531)mutants (Fig-
ures 3A and 3B). Thus, the serine protease
activity ofSVH-1 is required for its ability to
promote larval growth, but not for axon
regeneration.
When either the mutant SVH-1DCL or
SVH-1DK, lacking the C-type lectin or
kringle domain, respectively (Figure 1A),
was expressed in svh-1(ok2531) and
svh-1(ok2531); kmDp1/+ mutants, each
(Pjkk-1::svh-1Dcl or Pjkk-1::svh-1Dk)
was able to rescue defects in both larval
growth and axon regeneration (Figures
3A–3C). This indicates that the C-type
lectin and kringle domains are not essen-
tial for the functions of SVH-1.
SVH-1 Regulates Larval Growth via
Fibulin
In mammals, there are two mature forms
of plasminogen: a PAN-domain contain-ing form called Glu-Plasminogen (Glu-Plg) and a proteolytically
processed form lacking the PAN domain called Lys-Plasmin-
ogen (Lys-Plg) (Miles et al., 2003). Glu-Plg normally assumes a
more tightly packed conformation and shows relatively low acti-
vation kinetics, while Lys-Plg has amore extended conformation
that is more readily activated than Glu-Plg. We therefore
reasoned that deletion of the PAN domain might convert SVH-
1 to a more active form. We found that expression of SVH-
1DPAN, a truncation lacking the PANdomain, was able to rescuecember 11, 2014 ª2014 The Authors 1631
Figure 4. Relationship between SVH-1 and FBL-1
(A) Effect of SVH-1DPAN expression on gonad development. Nomarski images of animals are shown in the top panels. The posterior gonad arms of these animals
are shown in the middle panels. The bottom panels show schematic diagrams of the gonads. Gonadal sheath is indicated by red line. Eggs and germline cells are
shown with blue colors. In animals expressing SVH-1DPAN or fbl-1(hd43)mutants at adult stage, a part of the gonadal sheath structures became invisible by DIC
and the germ cells were disorganized and directly exposed to the body cavity. Photos are oriented anterior to the left and dorsal to the top. Scale bar, 50 mm.
(B) Effect of the svh-1mutation on the localization of FBL-1C::VENUS. Fluorescent images of animals expressing FBL-1C::VENUS are shown in the top panels.
Magnified images in the boxed areas are shown in the middle panels. Schematic diagrams of these images are shown in the bottom panels. Abnormal accu-
mulation of FBL-1C::VENUS in the ECM surrounding the pharynx in svh-1 mutants is indicated by red arrowheads. Scale bar, 10 mm.
(C) Effect of the svh-1mutation on the organization of pharyngeal muscle. Confocal images of animals stained by rhodamine-phalloidin are shown. Pharynxes are
indicated by yellow lines. Right panels show the expanded images of the terminal bulbs. In wild-type animals, no animals (n = 30) showed disorganization of the
pharyngeal muscle. In svh-1 mutants, 80% of animals (n = 30) showed such a phenotype. Scale bar, 10 mm.
(D) Suppression of the svh-1 phenotype by the fbl-1(hd43) mutation. Light microscopy of animals grown for 5 days is shown. Suppression of the svh-1 growth
defect was examined as described in Experimental Procedures. In svh-1mutants, no animals grew to the adult stage on 25 plates. In svh-1 fbl-1 double mutants,
animals grew to the adult stage on 8 out of 25 plates. Anterior is to the left. Scale bar, 50 mm.
(E) Model of SVH-1 functions regulating larval growth and axon regeneration.the larval arrest phenotype of svh-1 deletion mutants (Figure 3A);
however, adult animals became sick and were sterile. Further-
more, when SVH-1DPAN was expressed in wild-type animals,
the gonadal structure became disorganized and ruptured
(Figure 4A).
These phenotypes caused by SVH-1DPAN expression are
reminiscent of those observed in deletion mutants of the fbl-1
gene (Figure 4A), aC. elegans homolog of the ECMprotein fibulin
(Kubota et al., 2004; Hesselson et al., 2004). This raised the pos-1632 Cell Reports 9, 1628–1634, December 11, 2014 ª2014 The Autsibility that FBL-1 might be a target for SVH-1 protease activity.
Therefore, we examined the effect of the svh-1mutation on FBL-
1 protein expression and localization using an fbl-1c::venus
fusion gene expressed from its own promoter. FBL-1C::VENUS
is localized around the pharynx in wild-type animals (Kubota
et al., 2004; Hesselson and Kimble, 2006) (Figure 4B). In svh-
1(ok2531)mutants, however, the FBL-1C::VENUS fusion protein
accumulated abnormally at the surface of the pharynx, and the
pattern of FBL-1 accumulation was similarly affected (Figure 4B).hors
Quantification of fluorescence intensity showed a moderate, but
significant, increase in the amount of FBL-1C::VENUS in the ter-
minal bulb of svh-1 mutants (Figures S4A and S4B). In addition,
we observed that the terminal bulb was slightly distorted in
svh-1(ok2531) mutants, with disorganization of the pharyngeal
muscle (Figure 4C). This suggests that the impaired pharyngeal
pumping observed in svh-1mutants may be caused by the aber-
rant structure of the pharyngeal muscle.
An attractive hypothesis to explain these results is that the
larval arrest phenotype observed in svh-1 mutants is caused
by a pumping defect due to the abnormal accumulation of
FBL-1 around the pharynx. To test this possibility, we examined
the genetic interaction between svh-1 and fbl-1. svh-1(ok2531)
mutants were developmentally arrested at the L2 larval stage
and none of them grew into the adult stage (Figure 4D). However,
some of svh-1(ok2531) fbl-1(hd43) double mutants grew to the
adult stage and showed a normal frequency of pharyngeal
pumping (43 ± 9 times/20 s at 48 hr). Thus, the function of the
pharynx is restored in the double mutants. These results suggest
that the fbl-1(hd43) deletion mutation partially suppresses the
growth defect in svh-1 mutants. To confirm the suppression of
svh-1 by fbl-1, we examined the effect of fbl-1 RNAi on the larval
arrest phenotype in svh-1(ok2531) mutants. Following feeding
with fbl-1 RNAi bacteria, some fraction of the svh-1 mutants
grew to the adult stage (Figure S4C), indicating that the growth
defect in svh-1 mutants is partially suppressed by the fbl-1
RNAi. Taken together, these results suggest that the irregular
accumulation of FBL-1 around the pharynx contributes, at least
in part, to the larval growth defect seen in svh-1 mutants.
DISCUSSION
Mammalian HGF and MSP do not require protease activity in
order to activate their respective receptor tyrosine kinases,
Met and Ron (Gherardi et al., 2012). In contrast, mammalian
plasmin requires its protease activity to remodel ECM compo-
nents (Vassalli et al., 1991). SVH-1, a C. elegans plasminogen
family member, regulates axon regeneration after laser ablation
through its cognate receptor, tyrosine kinase SVH-2 (Li et al.,
2012) (Figure 4E). Activation of SVH-2 by SVH-1 does not require
SVH-1 protease activity (Li et al., 2012), reminiscent of HGF/MSP
signaling through Met/Ron. However, SVH-1 possesses an
intact catalytic triad similar to plasminogen, raising the possibility
that SVH-1 has other protease-dependent functions. In support
of this possibility, null mutations of svh-1 result in a larval growth
arrest phenotype, which is not observed in svh-2 null mutants.
Furthermore, regulation of larval growth by SVH-1 requires its
protease activity. Thus, SVH-1 is a dual-function protein, acting
both as a growth factor similar to HGF/MSP and as a plas-
minogen-like protease. The former function controls axon regen-
eration and the latter function regulates larval development
(Figure 4E). In contrast, in mammalian cells, these protease-
dependent and -independent functions aremediated by different
plasminogen family proteins, such as plasminogen and HGF/
MSP. These differences provide a new perspective on the evolu-
tion of HGF/MSP and plasminogen. Previous studies have sug-
gested that the plasminogen-related growth factors evolved
along with plasminogen from a common ancestral gene, whichCell Reduplicated to generate the precursors of the HGF/MSP and
the plasminogen/apolipoprotein (a) genes (Donate et al., 1994).
The discovery that C. elegans SVH-1 is a dual-function protein
supports the possibility that an ancient protein having dual
functions evolutionarily diverged into two functionally distinct
proteins in vertebrates (Figure 4E). Consistent with this, SVH-
1-like proteins are found in other invertebrates, such as oyster,
sea urchin, amphioxus, and some insects. In addition, we found
that oyster, sea urchin, and amphioxus have Met-like receptor
tyrosine kinases (Figure S1A), suggesting that HGF-like growth
factor signaling may also be conserved in these animals.
Our results show that the protease activity ofC. elegansSVH-1
is necessary for its regulation of larval growth (Figure 4E). Disrup-
tion of the svh-1 gene results in the functional impairment of
pharyngeal contraction and is associated with the abnormal
accumulation of FBL-1, a C. elegans homolog of fibulin, on the
surface of the pharynx. It is likely that the accumulation of FBL-
1 contributes to the larval arrest phenotype in svh-1 mutants,
as both a loss-of-function mutation of the fbl-1 gene and intro-
duction of fbl-1 RNAi are able to partially suppress the svh-1
defect in larval growth. Since the pharyngeal pumping defect
in svh-1 mutants worsens over time, it is likely that FBL-1 grad-
ually accumulates in the ECM of pharynx in these mutants. The
abnormal accumulation of FBL-1 would then physically interfere
with proper pharyngeal pumping, leading to the larval arrest
phenotype. Consistent with this, double mutants in which the
svh-1(ok2531) phenotype is suppressed by the fbl-1(hd43)muta-
tion exhibit a normal frequency of pharyngeal pumping, indi-
cating that the function of the pharynx is recovered. Alternatively,
the svh-1 loss-of-function phenotype may result from defects in
ECM remodeling that normally occur as the pharynx increases in
size during larval growth. If proteases are required for the soft-
ening of the ECM during growth, then inhibition of these prote-
ases could result in an overrigid ECM. A general, but limited,
model consistent with our results is that SVH-1 protease
promotes the softening of the ECM during growth, while FBL-1
promotes its stiffening by assembling into elastic fibers and
basement membranes. Thus, the svh-1 deletion mutation results
in inefficient reconstruction of the ECM, leading to the observed
physical constriction. Mammalian plasmin, which is an activated
form of plasminogen, directly cleaves fibulin-2 and fibulin-5
in vitro (Sasaki et al., 1996). In addition, partial digestion of fibu-
lin-5 induces its removal from the cell surface (Kapustin et al.,
2012). These results suggest that the regulation of fibulins by
plasminogen-like proteases is conserved among species.EXPERIMENTAL PROCEDURES
Feeding Assay
To determine feeding, fluorescein isothiocyanate (FITC)-labeled 0.5 mm of
polystyrene beads (Fluoresbrite Carboxylate Microspheres 0.50 mm Yellow
Green, Polysciences) were plated on 3 cm nematode growth medium (NGM)
dishes together with OP50. About 50 animals were plated to allow feeding
for 1 hr. The animals were then mounted to agar pads and FITC fluorescence
in the intestinal lumen was observed by fluorescent microscopy.
Pharyngeal Pumping Rate
Todetermine thepharyngealpumping rate, animalsweremounted toagarpads,
observed by eye under a Nikon Eclipse E800 microscope (603 objective), andports 9, 1628–1634, December 11, 2014 ª2014 The Authors 1633
the frequency of pumping over 20 s intervals was determined. In wild-type and
svh-1mutant, 20animalswere examined in eachcondition. In svh-1 fbl-1double
mutants, a total of 33 trials were executed in 3 animals.
Suppression of the svh-1 Growth Defect by the fbl-1 Mutation
Animals of the svh-1(ok2531)/nT1[qIs51] and svh-1 fbl-1(hd43)/nT1[qIs51]
genotype were grown from the adult stage and allowed to lay eggs on NGM
plates. After 24 hr, the parent animals were removed from the plates and incu-
bated for 4–5 days. GFP-negative animals that grew to the adult stage were
confirmed to have the ok2531 deletion by PCR.
Experiments with C. elegans were performed in accordance with the Regu-
lations on Animal Experiments at Nagoya University.
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